Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Germany sits at the top of the cost table for Cefpodoxime Proxetil, and 2025 didn't loosen its grip. German material started near USD 422,000/MT and finished the year close to USD 447,000/MT, roughly 5.9% higher. Two things pushed the same way: firm antibiotic demand, and cephalosporin intermediates that kept getting dearer. The global picture wasn't much different. USD 372,000/MT early in 2025, USD 394,000/MT by December, then USD 409,000/MT once Q2 2026 came around. Respiratory season did its usual work, feedstock did the rest, and the number ground steadily higher.
So what is it? Cefpodoxime Proxetil (CAS 80210-62-4, C20H22N4O10S) is a third-generation oral cephalosporin. It ships as the proxetil ester, a prodrug the body turns into active cefpodoxime on absorption. Making it starts from the cephalosporin nucleus, with 7-ACA and the intermediates downstream of it as the inputs that matter. The demand is broad-spectrum antibiotics, respiratory, urinary, and skin-structure infections mostly, and there's a solid paediatric share on top. Price-wise, four things drive it: what the cephalosporin intermediates cost, what compliance is running in China, how bad the respiratory season is, and how hard the generic makers are buying.
The rest of 2026 leans firm. Respiratory season keeps the generic makers in the market, and stock along the chain isn't heavy, just comfortable. Intermediates are firm. Chinese compliance costs are firm. So producer break-even keeps inching up, and that's really the whole story: steady gains, nothing sharp.
Two things could change it. Up: a jump in 7-ACA or the downstream intermediates, or a compliance shutdown somewhere in China. Down: a mild respiratory season, or generic buyers letting stock build. Either of those would soften the buying and put a lid on offers.
| Region | 2026 Price Range (USD/MT) | Outlook |
| Global Average | 405,000 - 440,000 | Firm antibiotic demand, dearer intermediates |
| United States | 455,000 - 495,000 | Import reliance and regulation keep the US firm |
| China | 335,000 - 368,000 | Integrated intermediate chain, the global low |
| Germany | 462,000 - 500,000 | Energy and compliance sustain the premium |
| India | 375,000 - 408,000 | Export capacity holds a firm middle |
The US ran USD 458,000/MT in Q2, up from USD 446,000/MT in Q1. Call it 2.7%. Imported intermediates cost more, antibiotic demand held its line, and up it went.
Why did the price of Cefpodoxime Proxetil change in Q2 2026 in United States?
Dearer cephalosporin intermediates lifted the cost base. Generic buying stayed steady, so supply and demand more or less matched. USD 458,000/MT was the result.
China's still the cheapest place to buy, but offers firmed anyway, to USD 338,000/MT from USD 328,000/MT, about 3.0%. Dearer 7-ACA and compliance costs were behind it.
Why did the price of Cefpodoxime Proxetil change in Q2 2026 in China?
Higher intermediate and compliance costs pushed the bottom up. Export demand stayed steady and thinned what was around. Prices held near USD 338,000/MT.
Germany was the priciest again, at USD 465,000/MT, up about 2.6% from USD 453,000/MT. Heavy energy and compliance costs, firm European antibiotic demand: the two met, and the number rose.
Why did the price of Cefpodoxime Proxetil change in Q2 2026 in Germany?
Energy and regulation kept break-even high. European demand held offtake. The quarter came in near USD 465,000/MT.
India firmed to USD 378,000/MT, up roughly 3.0% from USD 367,000/MT. Pricier imported intermediates, steady export demand from the formulation houses, and that was enough.
Why did the price of Cefpodoxime Proxetil change in Q2 2026 in India?
Dearer intermediates raised the bottom while export offtake held firm. Call it USD 378,000/MT.
The US opened 2026 at USD 446,000/MT, about 1.4% over Q4. Winter demand and firmer intermediates kept the climb alive.
Why did the price of Cefpodoxime Proxetil change in Q1 2026 in United States?
Respiratory season plus rising intermediate costs held the market firm at USD 446,000/MT.
China started the year at USD 328,000/MT, up around 1.2% from Q4. Output came back after the holidays, intermediates firmed, and offers held up.
Why did the price of Cefpodoxime Proxetil change in Q1 2026 in China?
Dearer 7-ACA and steady export demand kept the market near USD 328,000/MT.
Germany hit USD 453,000/MT in Q1, about 1.3% over Q4, as heavy compliance costs and firm winter demand nudged it up.
Why did the price of Cefpodoxime Proxetil change in Q1 2026 in Germany?
High energy and compliance costs, plus steady demand, carried the quarter to USD 453,000/MT.
India began at USD 367,000/MT, roughly 1.1% over Q4, on firmer intermediates and steady export demand.
Why did the price of Cefpodoxime Proxetil change in Q1 2026 in India?
Dearer intermediates and firm export offtake lifted the market to USD 367,000/MT.
Six quarters, six gains. That's the Cefpodoxime Proxetil story lately. USD 378,000/MT in Q2 2025, then USD 386,000/MT, then USD 394,000/MT, then USD 400,000/MT in Q1 2026, and USD 409,000/MT in Q2, about 8.2% across the run. Firm seasonal antibiotic demand and dearer cephalosporin intermediates did it.
| Quarter | Price (USD/MT) | QoQ Change | Direction |
| Q2 2026 | 409,000 | +2.3% | ↑ Rising |
| Q1 2026 | 400,000 | +1.5% | ↑ Rising |
| Q4 2025 | 394,000 | +2.1% | ↑ Rising |
| Q3 2025 | 386,000 | +2.1% | ↑ Rising |
| Q2 2025 | 378,000 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Cefpodoxime Proxetil firmed through 2025, plain and simple. The average opened near USD 372,000/MT and closed around USD 394,000/MT, up roughly 5.9%. Respiratory season, dearer cephalosporin intermediates, firm Chinese compliance costs: those set the tone.
The US went from about USD 415,000/MT early on to USD 440,000/MT by Q4, up roughly 6.0%. Generic antibiotic demand held firm, respiratory season kept offtake steady, and imported intermediates cost a bit more every quarter. Demand and feedstock never pulled apart.
China climbed from around USD 305,000/MT to USD 324,000/MT, about 6.2%. Dearer 7-ACA and compliance costs held offers up, and export demand stayed steady. Intermediate costs were the whole theme.
Germany rose from roughly USD 422,000/MT to USD 447,000/MT, up about 5.9%. Heavy energy and compliance lifted production economics, and firm European antibiotic demand held offtake. Cost pressure, in other words.
India firmed from about USD 342,000/MT to USD 363,000/MT, a 6.1% gain. Steady export demand, rising imported intermediates. Feedstock did the driving.
Expert Market Research: Your Source for Real-Time Cefpodoxime Proxetil Price Intelligence
Expert Market Research keeps Cefpodoxime Proxetil prices under constant watch, in every region worth watching, on both sides of the trade. We go after the why, not just the number: what the cephalosporin intermediates are doing, what compliance is costing in China, how the respiratory season is shaping up, and how the generic makers are buying. The forecasts pull from feedstock economics, trade-flow data, capacity use, and a read on geopolitical risk across the map. Talk to Expert Market Research for Cefpodoxime Proxetil pricing, analysis shaped to your questions, and procurement support.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Almost all of it goes into broad-spectrum oral antibiotics, for respiratory, urinary, and skin-structure infections, and gonorrhoea. There's a solid paediatric share too, served by dispersible and suspension forms.
In Q2 2026 it ran USD 458,000/MT in the US, USD 338,000/MT in China, USD 465,000/MT in Germany, and USD 378,000/MT in India. Germany's the priciest, on energy and compliance.
It rose. From about USD 372,000/MT early in 2025 to USD 394,000/MT by Q4, roughly 5.9%, on firm antibiotic demand and dearer cephalosporin intermediates.
Three things. Respiratory season, rising 7-ACA and downstream intermediate costs, and firm compliance costs at the Chinese producers.
Figure a USD 405,000 to 440,000/MT band for the rest of 2026, held up by firm antibiotic demand and rising intermediate costs.
Germany and the US are dearest, on energy, compliance, import, and regulation. India sits in the middle, export-focused. China's cheapest, on its integrated intermediate chain.
Every month. For live pricing, reach the Expert Market Research team directly.
Mainly the cephalosporin intermediates, compliance, and the respiratory season. Tariffs, export licences, and freight can shake things short term.
China anchors the intermediate chain and holds the big capacity, with India a major API exporter behind it. Move intermediate costs or compliance and every market feels it inside a quarter or two.
Line contracts up with the respiratory season, weigh fixed price against index-linked supply, and get cover set before the seasonal firming. 7-ACA and the intermediates are the earliest read on the base.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.